Why is Acutaas Chemical falling/rising?

Recent Price Movement and Market Context

After enduring a six-day consecutive fall, Acutaas Chemicals reversed its downward trend on 09-Dec, touching an intraday high of ₹1,690.55, marking a 2.52% increase from its low of ₹1,614.80. Despite this recovery, the stock underperformed its sector by 0.42% on the day, indicating some lingering caution among traders. The share price remains above its 50-day, 100-day, and 200-day moving averages, signalling a generally positive medium to long-term trend, although it is still below the 5-day and 20-day averages, suggesting short-term volatility.

Strong Long-Term Growth Driving Investor Confidence

Acutaas Chemicals has demonstrated impressive growth metrics that underpin its recent price resilience. The company’s net sales have expanded at an annual rate of 27.10%, while operating profit has surged by 32.44%. Notably, net profit growth stands at a remarkable 63.28%, supported by very positive quarterly results over the last five consecutive quarters. The latest half-year figures reveal net sales of ₹513.44 crores, growing 21.27%, and a return on capital employed (ROCE) of 21.30%, which is among the highest in its peer group. Additionally, the inventory turnover ratio of 5.74 times indicates efficient management of stock levels, further bolstering operational strength.

Institutional Backing and Market Liquidity

Investor participation has notably increased, with delivery volumes on 08-Dec rising by 37.14% compared to the five-day average, reaching 1.13 lakh shares. This heightened activity suggests renewed interest from both retail and institutional investors. Institutional holdings are substantial at 39.44%, reflecting confidence from well-resourced investors who typically conduct thorough fundamental analysis. The stock’s liquidity remains adequate, supporting trade sizes of approximately ₹0.59 crore based on recent average traded values, which facilitates smoother transactions for market participants.

Valuation Considerations and Risks

Despite the strong fundamentals, Acutaas Chemicals carries a relatively expensive valuation. The price-to-book ratio stands at 9.6, which is high, although it trades at a discount compared to its peers’ historical averages. The company’s return on equity (ROE) is 15.8%, and while profits have surged by 139.8% over the past year, the stock’s price appreciation of 47.58% suggests a PEG ratio of 0.4, indicating that the market may still be undervaluing its growth potential. Investors should remain mindful of these valuation metrics when considering entry points.

Consistent Outperformance and Long-Term Returns

Acutaas Chemicals has delivered consistent returns over the last three years, generating a cumulative gain of 252.00%, significantly outperforming the Sensex’s 36.16% over the same period. Year-to-date, the stock has appreciated by 54.75%, far exceeding the benchmark’s 8.35% rise. This sustained outperformance highlights the company’s strong growth trajectory and market positioning, which continue to attract investor interest despite short-term fluctuations.

Conclusion

The recent rise in Acutaas Chemicals’ share price on 09-Dec can be attributed to its solid financial performance, robust growth indicators, and increased investor participation following a period of decline. While the stock remains somewhat expensive on valuation metrics, its consistent profitability, strong institutional backing, and superior returns relative to benchmarks provide a compelling case for its upward momentum. Investors should weigh these factors carefully alongside market conditions to make informed decisions.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →